logo BDSP

Base documentaire


  1. Evaluation of epilepsy management in a developing country : a prospective study of 407 patients.

    Article - En anglais

    407 patients (248 men, 159 women) of epilepsy attending the neurology clinic were evaluated to find out the profile of epilepsy, cost-effectiveness of various investigations, therapeutic regimens and efficacy of referring physicians in a developing country.

    At the time of onset of seizures 67.2% of patients were in the second and third decade.

    Generalised tonic clonic seizures were the commonest seizure type seen.

    Specific aetiology was established in 20.8% cases only.

    Neurocysticercosis was the commonest cause observed.

    The main source of referral (50.1%) was general practitioners.

    Referral diagnosis was incomplete in 52.8% of the cases.

    Investigations did not alter the diagnosis in 62.5% cases.

    The EEG was useful in the management of 15.1% cases of epilepsy.

    The skull x-ray and chest x-ray were abnormal in 1.7% and 2% cases respectively.

    CT scan revealed abnormality in 39.4% cases.

    Most of the patients were treated with monotherapy.

    Phenytoin, phenobarbitone and carbamazepine were the common drug used.

    Out of 246 cases who were started on anticonvulsant therapy prior to referral, the choice of drug was wrong in 78 (31.7%) cases and dose was inappropriate in 121 (49.2%) cases.

    It was concluded that most important factor for cost effective management of epilepsy is proper clinical evaluation and education of general physicians in this direction.

    Mots-clés Pascal : Epilepsie, Coût spécifique, Economie santé, Attitude, Homme, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie

    Mots-clés Pascal anglais : Epilepsy, Specific cost, Health economy, Attitude, Human, Nervous system diseases, Central nervous system disease, Cerebral disorder

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0422784

    Code Inist : 002B17A03. Création : 10/04/1997.